Changes in the characteristics of the bone marrow during therapy for acute non-lymphocytic leukemia: Relationship to response to remission induction therapy
- 1 May 1985
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 21 (5) , 563-571
- https://doi.org/10.1016/0277-5379(85)90081-1
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Prediction of response of acute nonlymphocytic leukaemia to therapy with ‘high dose’ cytosine arabinosideBritish Journal of Haematology, 1984
- Relationship between the per cent of marrow cells in S phase and the outcome of remission‐induction therapy for acute nonlymphocytic leukaemiaBritish Journal of Haematology, 1984
- Recognition of drug resistance during remission induction therapy for acute non-lymphocytic leukemia: Utility of day 6 bone marrow biopsyLeukemia Research, 1983
- Treatment of acute myelocytic leukemia: a study by cancer and leukemia group BBlood, 1981
- Evaluation of in vitro predictive assays for acute myelocytic leukemiaAnnals of Hematology, 1980
- High dose cytosine arabinoside (HDARAC) in refractory acute leukemiaCancer, 1979
- Treatment of acute nonlymphocytic leukemia: use of anthracycline- cytosine arabinoside induction therapy and comparison of two maintenance regimensBlood, 1979
- Remission induction in acute nonlymphocytic leukemia: Comparison of a seven‐day and ten‐day infusion of cytosine arabinoside in combination with adriamycinMedical and Pediatric Oncology, 1979
- Failure of remission induction in acute myelocytic leukemiaMedical and Pediatric Oncology, 1978
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976